Growth hormone axis research often looks at two pituitary receptor systems at once: the GHRH receptor and the ghrelin receptor (GHS-R1a). The CJC-1295 + Ipamorelin blend supplies one ligand for each in a single vial. This overview covers the two components, why the pairing is studied, the trade-offs of a fixed ratio, and what a two-component COA should report. For each compound on its own, see the CJC-1295 no DAC overview and the Ipamorelin overview.
The Two Components
CJC-1295 (no DAC)
CJC-1295 without DAC, also called modified GRF (1-29), is a 29-amino-acid analog of the active N-terminal region of GHRH with four amino acid substitutions intended to resist enzymatic breakdown. Its molecular weight is about 3,368 Da. Unlike the DAC version, it carries no drug affinity complex, so it lacks the albumin-binding lysine linker. See CJC-1295 DAC vs no DAC.
Ipamorelin
Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, of about 712 Da. It acts at the ghrelin receptor and is often described as selective, because early characterization work reported little effect on other pituitary hormones compared with older GHRPs.
Why Researchers Study the Pairing
GHRH-receptor and ghrelin-receptor signaling use different intracellular routes, and preclinical studies examine how the two inputs combine at pituitary somatotroph cells. A blend supplies both ligands in a fixed 1:1 ratio (5mg each per vial). The trade-off is flexibility: the ratio cannot be varied between experimental arms. See CJC-1295 vs Ipamorelin and CJC-1295/Ipamorelin vs Tesamorelin.
Common In-Vitro Designs
- Receptor-binding and cAMP assays comparing each ligand alone with the combination.
- Pituitary cell-culture models measuring secretagogue-driven responses.
- Receptor desensitization and recovery studies.
- Analytical method development for separating a 29-residue and a 5-residue peptide in one sample.
Findings in receptor assays or cell models do not establish any effect in people.
What a Two-Component COA Should Report
A useful blend certificate reports each component separately: two HPLC peaks with their own purity values, and mass spectrometry confirming both identities (about 3,368 Da and about 712 Da). It should also make clear that the CJC-1295 is the no-DAC form, since the DAC version has a noticeably higher mass. See how to read an HPLC chromatogram and the peptide COA glossary. Published lot certificates are listed in our COA library.
Specifications at a Glance
- Components: CJC-1295 no DAC (GHRH analog, 29 aa) + Ipamorelin (GHS pentapeptide)
- Size: 5mg / 5mg in one vial
- Form: co-lyophilized powder
- Verification: HPLC purity and MS identity, third-party tested
Where to Go Next
View the CJC-1295 + Ipamorelin Blend 5/5mg, the single-compound CJC-1295 no DAC and Ipamorelin pages, or browse the GH-Axis Research and Peptide Blends collections. Related: Tesamorelin + Ipamorelin blend overview, Sermorelin overview, and the pillar Researcher's Guide to Peptides in 2026.
Frequently Asked Questions
What is in a CJC-1295 + Ipamorelin blend?
One lyophilized vial containing 5mg of CJC-1295 without DAC, a 29-amino-acid GHRH analog, and 5mg of Ipamorelin, a ghrelin-receptor pentapeptide.
Is the CJC-1295 in this blend the DAC or no-DAC form?
It is the no-DAC form, also called modified GRF (1-29). It has no drug affinity complex attached.
Why pair a GHRH analog with a ghrelin-receptor agonist in research?
The two ligands act at different pituitary receptors with different signaling routes, so preclinical studies compare each alone and in combination.
What should a blend COA show?
Separate HPLC purity values for each component and mass spectrometry confirming both identities, tied to a lot number and test date that match the vial.
Is this blend for human use?
No. It is sold for laboratory research use only, not for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.
All products referenced in this article are sold strictly for laboratory research use only. They are not for human or veterinary use, are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. A Certificate of Analysis is an analytical record for a tested sample; it is research verification only and is not a statement of safety or suitability for any use outside a qualified laboratory.
